Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics
Otto Simonsson, Peter S. Hendricks, Richard Chambers, et al.
Journal of Affective Disorders (2023) Vol. 326, pp. 105-110
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Extended difficulties following the use of psychedelic drugs: A mixed methods study
Jules Evans, Oliver Robinson, Eirini K. Argyri, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0293349-e0293349
Open Access | Times Cited: 58
Essentials of Informed Consent to Psychedelic Medicine
Mason Marks, Rebecca Weintraub Brendel, Carmel Shachar, et al.
JAMA Psychiatry (2024) Vol. 81, Iss. 6, pp. 611-611
Closed Access | Times Cited: 17
Suicide of a Patient Shortly After Psilocybin-Assisted Psychedelic Therapy. A Case Report
Felix Müller, Thomas Sauer, Corina Hänny, et al.
Psychiatry Research (2025) Vol. 345, pp. 116381-116381
Open Access | Times Cited: 2
Therapeutic mechanisms of psychedelics and entactogens
Boris D. Heifets, David E. Olson
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 104-118
Closed Access | Times Cited: 29
Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive Disorder
Brandon Weiss, Leor Roseman, Bruna Giribaldi, et al.
International Journal of Mental Health and Addiction (2024) Vol. 22, Iss. 2, pp. 806-841
Open Access | Times Cited: 11
A framework for assessment of adverse events occurring in psychedelic-assisted therapies
Roman Palitsky, Deanna M. Kaplan, John Perna, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 8, pp. 690-700
Closed Access | Times Cited: 11
Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA
Abigail E. Calder, Gregor Hasler
Journal of Affective Disorders (2024) Vol. 365, pp. 258-264
Open Access | Times Cited: 8
Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles
Sophie A. Rogers, Elizabeth A. Heller, Gregory Corder
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences
Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Longitudinal associations between psychedelic use and psychotic symptoms in the United States and the United Kingdom
Ludwig Honk, Cecilia U. D. Stenfors, Simon B. Goldberg, et al.
Journal of Affective Disorders (2024) Vol. 351, pp. 194-201
Closed Access | Times Cited: 7
Keeping the promise: a critique of the current state of microdosing research
Rotem Petranker, Thomas Anderson, Emily C. Fewster, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 5
Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor
Ram Harari, Ipsita Chatterjee, Dmitriy Getselter, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109686-109686
Open Access | Times Cited: 5
Coming back together: a qualitative survey study of coping and support strategies used by people to cope with extended difficulties after the use of psychedelic drugs
Oliver Robinson, Jules Evans, David Luke, et al.
Frontiers in Psychology (2024) Vol. 15
Open Access | Times Cited: 5
Psychedelics in Psychiatry: Oh, What A Trip!
Gregory A. Fonzo, Charles B. Nemeroff, Ned H. Kalin
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 1-5
Closed Access
Primum Non Nocere: The Onus to Characterize the Potential Harms of Psychedelic Treatment
Sharmin Ghaznavi, Jeremy N. Ruskin, Stephen J. Haggerty, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 47-53
Closed Access
A prospective ecological momentary assessment study of an ayahuasca retreat: exploring the salutary impact of acute psychedelic experiences on subacute affect and mindfulness skills in daily life
Sharon R. Sznitman, Yoel A. Behar, Sheila Daniela Dicker‐Oren, et al.
Psychopharmacology (2025)
Open Access
Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users’ Patterns of Use and Perceived Effects
Carrie Cuttler, Amanda Stueber, Jonathan J. Simone, et al.
Journal of Psychoactive Drugs (2025), pp. 1-13
Closed Access
Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin Use
David S. Mathai, Daniel E. Roberts, Sandeep M. Nayak, et al.
Journal of Psychoactive Drugs (2025), pp. 1-12
Open Access
Exploring factors associated with the intensity of a mystical experience following naturalistic psychedelic use: A retrospective survey
Bruno Roméo, E. Kervadec, Baptiste Fauvel, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111300-111300
Closed Access
Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case report
John Perna, Justin Trop, Roman Palitsky, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Synthetic surprise as the foundation of the psychedelic experience
Roberto De Filippo, Dietmar Schmitz
Neuroscience & Biobehavioral Reviews (2024) Vol. 157, pp. 105538-105538
Open Access | Times Cited: 4
Bridging the gap: (a)typical psychedelic and near-death experience insights
Pauline Fritz, Nicolas Lejeune, Paolo Cardone, et al.
Current Opinion in Behavioral Sciences (2024) Vol. 55, pp. 101349-101349
Open Access | Times Cited: 4
Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts
Ar Wilson-Poe, Ka Hoffman, Kellie Pertl, et al.
Journal of Psychoactive Drugs (2024), pp. 1-8
Closed Access | Times Cited: 4
On Minimizing Risk and Harm in the Use of Psychedelics
Jules Evans, Marc Aixalà, B. Anderson, et al.
Psychiatric Research and Clinical Practice (2025), pp. n/a-n/a
Open Access
Can psychedelic use benefit meditation practice? Examining individual, psychedelic, and meditation-related factors
Zishan Jiwani, Simon B. Goldberg, Jack Stroud, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0310160-e0310160
Open Access
Page 1 - Next Page

Scroll to top